SENS Foundation is a non-profit organization* which works to develop, promote and ensure widespread access to regenerative medicine solutions to the disabilities and diseases of aging. Our focus is on the Strategies for Engineered Negligible Senescence (SENS) identified by our Chief Science Officer, Dr Aubrey de Grey, combining direct research efforts with education, affiliation and outreach programs. We support key research through our own institute and through a variety of affiliated universities and research organizations.

Our research is governed by a strategic agenda to demonstrate the feasibility of SENS and regenerative medicine approaches, and therefore drive broader involvement. We are already assembling a world class team of advisors; we shall continue to build on the successful biennial Aging (US) and SENS (UK) Conferences; we are expanding affiliations to include non-profits with complementary missions, research organizations, government support, and technology transfer with mainstream biotechnology companies; and we are working hard to raise awareness and interest in the general community.

The challenge is not small. We are proposing nothing less than a transformation of medicine; away from the increasingly burdensome and unprofitable chase to treat pathologies, and towards a functional and, for society as a whole, more cost-effective approach to maintaining and extending individual health.

We hope that you will share our vision, and that you will join us on what promises to be a remarkable journey.

*SENS Foundation is a California non-profit organization. SENS Foundation is in the process of applying for recognition of exemption from taxation under section 501(c)(3) of the Internal Revenue Code. The organization expects to receive tax-exempt status effective its date of incorporation. Donations to organizations exempt under section 501(c)(3) are deductible from federal income tax.